期刊文献+

早产儿视网膜病变高危因素分析 被引量:2

Analysis of risk factors of premature retinopathy
原文传递
导出
摘要 探讨早产儿视网膜病变(ROP)的发生情况及其危险因素。方法对孕周〈36周、出生体质量〈2000g的244例早产儿在4周时进行眼底检查。根据ROP国际诊断分期法进行诊断和分期。结果244例早产儿中患有不同程度ROP者49例(其中ROPI期37例,ROPⅡ期l0例,ROPⅢ期2例),ROP发生率为20.1%。孕周、出生体质量、吸氧、母亲妊娠并发症、酸中毒、呼吸暂停、PaO2的变化、机械通气及感染对ROP的发生具有明显影响(均P〈0.05);且孕周越短、出生体质量越小,ROP发生率越高(均P〈0.05)。结论ROP的发生与孕周、出生体质量、吸氧、母亲妊娠并发症、酸中毒、呼吸暂停、Pa02变化及感染、机械通气等因素有关,其中孕周、出生体质量、吸氧、呼吸暂停是ROP的独立危险因素。 To analyze the incidence and risk factors of retinopathy of prematurity (ROP). Methods 244 premature children 4 weeks after birth, which neonatal gestational age were 〈 36 weeks, birth weight were 〈 2 000g,were taken fundus examination. ROP stage at diagnosis, according to international law for the diagnosis and staging. Results 244 patients with varying degrees of premature children with ROP in 49 cases( including 37 ca- ses ofROP I ,ROP 1I of the 10 cases,ROP Ⅲ 2 cases) ,ROP rate was 20. 1%. Gestational age,birth weight,oxy- gen, mother pregnancy complications, acidosis, apnea, PaO2 changes, mechanical ventilation and infection on the inci- dence of ROP had a significant effect ( all P 〈 0.05 ) ; and shorter gestational age, birth weight, smaller, ROP incidence higher( all P 〈 0.05). Conclusion The incidence of ROP and gestational age,birth weight,oxygen,mother pregnan- cy complications, acidosis, apnea, PaO2 changes and infection, mechanical ventilation and other factors, and the gesta- tional age, birth weight, oxygen, apnea were independent risk factors for ROP.
出处 《中国基层医药》 CAS 2011年第20期2768-2769,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 视网膜病变 早产儿 危险因素 Retinopathy Prematurity Risk factors.
  • 相关文献

参考文献14

  • 1金汉珍等主编..实用新生儿学 第3版[M].北京:人民卫生出版社,2003:1078.
  • 2Gilbert C, Rahi J, Eckstein M, et al. Retinopathy of prematurity in middle-income coutries. Lancet, 1997,350 (9070) : 12-14. 被引量:1
  • 3郜欣.早产儿视网膜病变[J].国外医学(眼科学分册),1995,19(2):119-123. 被引量:30
  • 4Shah VA, Yeo CL, Ling YL, et al. Incidence, risk factors of retinopathy of prematufity among very low birth weight infants in Singapore. Ann Acad Med Singapore ,2005,34 (2) : 169-178. 被引量:1
  • 5Muller H, Weiss C, Kuntz S ,et al. Supplement oxygen a hseful conservative treatment option. Clin Pediatrics,2005,217(2) :53-60. 被引量:1
  • 6Gupta VP, Dhaliwal U, Sharma R, et al. Retinopathy of prematurity-risk factors. India J Pediar,2004,71 (10) :887-892. 被引量:1
  • 7Fledilius HC, Kjer B. Surveillance for retinopathy of prematurity in a Danish country. Epidemiological experience over 20 year. Acta Ophthalmol Stand,2004,82( 1 ):38-41. 被引量:1
  • 8薛爱丽,单若冰,于海清,周占宇.早产儿视网膜病变发生率及危险因素分析[J].齐鲁医学杂志,2008,23(4):298-300. 被引量:5
  • 9Smith LE. Pathogenesis of retinopathy of prematufity. Semin Neonatol,2003,8(6) :469-473. 被引量:1
  • 10Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurely. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology, 1991,98 ( 11 ) : 1628-1640. 被引量:1

二级参考文献36

  • 1黎晓新.我国早产儿视网膜病变特点和筛查指南[J].中华眼底病杂志,2004,20(6):384-386. 被引量:140
  • 2尹虹,黎晓新,李慧玲,张巍.早产儿视网膜病变的筛查及其相关因素分析[J].中华眼科杂志,2005,41(4):295-299. 被引量:76
  • 3高磊,赵秀芹,Wilson Yip,林顺潮.早产儿视网膜病变[J].中华眼底病杂志,2005,21(5):337-340. 被引量:30
  • 4米雪松,赵培泉.世界各国ROP筛查标准概况[J].中国实用眼科杂志,2006,24(9):879-882. 被引量:20
  • 5Ciardella AP,Klancnik J,Schiff W,et al.Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates:an optical coherence tomography study.Br J Ophthalmol 2004;88(9):1131-1136. 被引量:1
  • 6Nelson ML,Martidis A.Managing cystoid macular edema after cataract surgery.Curr Opin Ophthalmol 2003;14(1):39-43. 被引量:1
  • 7Gillies MC,Simpson JM,Luo W,et al.A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration:one-year results.Arch Ophthalmol 2003;121(5):667-673. 被引量:1
  • 8Moshfeghi AA,Rosenfeld PJ,Puliafito CA,et al.Systemic bevacizumab (avastin) therapy for neovascular age-related macular degeneration:twenty-four-week results of an uncontrolled,open-label clinical study.Ophthalmology 2006;113(11):11-12. 被引量:1
  • 9Shah PK,Narendran V,Tawansy KA,et al.Intravitreal bevacizumab (avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.Indian Ophthalmol 2007;55(1):75-76. 被引量:1
  • 10Quiroz-Mercado H,Martinez-Castellanos MA,Hernandez-Rojas ML,et al.Antiang-iogenic therapy with intravitreal bevacizumab for retino-pathy of prematurity.Retina 2008;28(3):19-25. 被引量:1

共引文献48

同被引文献18

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部